Comparative efficacy and tolerability of probiotics for antibiotic-associated diarrhea: Systematic review with network meta-analysis

United European Gastroenterology Journal

Volumn 6, Issue 2, 2018, Pages 169-180

  Cai, Jiayi ^a,b   Zhao, Chunyang ^c   Du, Yajie ^a   Zhang, Yaqiong ^a   Zhao, Mingyi ^a   Zhao, Qingchun ^a,b  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

antibiotic associated diarrhea; Clostridium difficile infection; network meta analysis; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ABDOMINAL PAIN; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; BACILLUS CLAUSII; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; DRUG EFFICACY; DRUG TOLERABILITY; EPIGASTRIC PAIN; HUMAN; INCIDENCE; INFECTION RATE; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS CASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; META ANALYSIS; NAUSEA; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SACCHAROMYCES BOULARDII; SYSTEMATIC REVIEW; VOMITING;

EID: 85042541180     PISSN: 20506406     EISSN: 20506414     Source Type: Journal    
DOI: 10.1177/2050640617736987     Document Type: Review

References (34)

1. Pozzoni P, Riva A, Bellatorre AG, Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: A single-center, randomized, double-blind, placebo-controlled trial. Am J Gastroenterol 2012; 107: 922–931.
2. Dietrich CG, Kottmann T, Alavi M. Commercially available probiotic drinks containing Lactobacillus casei DN-114001 reduce antibiotic-associated diarrhea. World J Gastroenterol 2014; 20: 15837–15844.
3. Parkes GC, Sanderson JD, Whelan K. The mechanisms and efficacy of probiotics in the prevention of Clostridium difficile-associated diarrhoea. Lancet Infect Dis 2009; 9: 237–244.
4. Korhonen R, Korpela R, Moilanen E. Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid. Inflammation 2002; 26: 207–214.
5. Lönnermark E, Friman V, Lappas G, Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol 2010; 44: 106–112.
6. Allen SJ, Wareham K, Wang D, Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): A randomised, double-blind, placebo-controlled, multicentre trial. Lancet 2013; 382: 1249–1257.
7. Cimperman L, Bayless G, Best K, A randomized, double-blind, placebo-controlled pilot study of Lactobacillus reuteri ATCC 55730 for the prevention of antibiotic-associated diarrhea in hospitalized adults. J Clin Gastroenterol 2011; 45: 785–789.
8. Song HJ, Kim JY, Jung SA, Effect of probiotic Lactobacillus (Lacidofil® Cap) for the prevention of antibiotic-associated diarrhea: A prospective, randomized, double-blind, multicenter study. J Korean Med Sci 2010; 25: 1784–1791.
9. Fox MJ, Ahuja KD, Robertson IK, Can probiotic yogurt prevent diarrhoea in children on antibiotics? A double-blind, randomised, placebo-controlled study. BMJ Open 2015; 5: e006474–e006474.
10. Gao XW, Mubasher M, Fang CY, Dose-response efficacy of a proprietary probiotic formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea prophylaxis in adult patients. Am J Gastroenterol 2010; 105: 1636–1641.
11. Sampalis J, Psaradellis E, Rampakakis E. Efficacy of BIO K + CL1285® in the reduction of antibiotic-associated diarrhea—a placebo controlled double-blind randomized, multi-center study. Arch Med Sci 2010; 6: 56–64.
12. Scahill SL. Probiotics. J Prim Health Care 2013; 5: 81–81.
13. Goldenberg JZ, Lytvyn L, Steurich J, Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev 2015. CD004827.
14. Videlock EJ, Cremonini F. Meta-analysis: Probiotics in antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2012; 35: 1355–1369.
15. Hempel S, Newberry SJ, Maher AR, Probiotics for the prevention and treatment of antibiotic-associated diarrhea. JAMA 2012; 18: 1959–1969.
16. Li BZ, Threapleton DE, Wang JY, Comparative effectiveness and tolerance of treatments for Helicobacter pylori: Systematic review and network meta-analysis. BMJ 2015; 351: h4052–h4052.
17. Liberati A, Altman DG, Tetzlaff J, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Med 2009; 6: e1000100–e1000100.
18. Higgins J and Green S. Cochrane handbook for systematic reviews of interventions, v.5.1.0. Cochrane Collaboration, www.cochrane-handbook.org (2011, accessed 21 September 2016)
19. Centre for Reviews and Dissemination. Systematic Reviews: CRD s Guidance for Undertaking Reviews in Health Care (Internet). York, England: University of York, www.crd.york.ac.uk/PROSPERO. (2009, accessed 30 September 2016)
20. Engels EA, Schmid CH, Terrin N, Heterogeneity and statistical significance in meta-analysis: An empirical study of 125 meta-analyses. Stat Med 2000; 19: 1707–1728.
21. Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Stat Med 2002; 21: 1575–1600.
22. 2in assessing heterogeneity may mislead. BMC Med Res Methodol 2008; 8: 79–79.
23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
24. Veroniki AA, Jackson D, Viechtbauer W, Methods to estimate the between-study variance and its uncertainty in meta-analysis. Res Synth Methods 2016; 7: 55–79.
25. Chaimani A, Higgins JP, Mavridis D, Graphical tools for network meta-analysis in STATA. PLoS One 2013; 8: e76654–e76654.
26. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088–1101.
27. Salanti G, Ades AE, Ioannidis JP. Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: An overview and tutorial. J Clin Epidemiol 2011; 64: 163–171.
28. Higgins JP, Jackson D, Barrett JK, Consistency and inconsistency in network meta-analysis: Concepts and models for multi-arm studies. Res Synth Methods 2012; 3: 98–110.
29. Dias S, Welton NJ, Caldwell DM, Checking consistency in mixed treatment comparison meta-analysis. Stat Med 2010; 29: 932–944.
30. Dias S, Sutton AJ, Welton NJ, et al. NICE DSU technical support document 3: heterogeneity: subgroups, meta- regression, bias and bias-adjustment. National Institute for Health and Care Excellence, www.nicedsu.org.uk. (2012, accessed 25 September 2016)
31. Knapp G, Hartung J. Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003; 22: 2693–2710.
32. Guyatt G, Oxman AD, Sultan S, GRADE guidelines: 11. Making an overall rating of confidence in effect estimates for a single outcome and for all outcomes. J Clin Epidemiol 2013; 66: 151–157.
33. Jafarnejad S, Shab-Bidar S, Speakman JR, Probiotics reduce the risk of antibiotic-associated diarrhea in adults (18–64 years) but not the elderly (>65 years): A meta-analysis. Nutr Clin Pract 2016; 31: 502–513.
34. Beausoleil M, Fortier N, Guénette S, Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: A randomized, double-blind, placebo-controlled trial. Can J Gastroenterol 2007; 21: 732–736.